Laboratory of Neurosciences, National Institute on Aging Intramural Research Program, BRC 5C214, Baltimore, MD, USA.
Laboratory of Neurosciences, National Institute on Aging Intramural Research Program, BRC 5C214, Baltimore, MD, USA; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Neurobiol Aging. 2018 Jan;61:52-65. doi: 10.1016/j.neurobiolaging.2017.09.016. Epub 2017 Sep 22.
Parkinson's disease (PD) is characterized by accumulations of toxic α-synuclein aggregates in vulnerable neuronal populations in the brainstem, midbrain, and cerebral cortex. Recent findings suggest that α-synuclein pathology can be propagated transneuronally, but the underlying molecular mechanisms are unknown. Advances in the genetics of rare early-onset familial PD indicate that increased production and/or reduced autophagic clearance of α-synuclein can cause PD. The cause of the most common late-onset PD is unclear, but may involve metabolic compromise and oxidative stress upstream of α-synuclein accumulation. As evidence, the lipid peroxidation product 4-hydroxynonenal (HNE) is elevated in the brain during normal aging and moreso in brain regions afflicted with α-synuclein pathology. Here, we report that HNE increases aggregation of endogenous α-synuclein in primary neurons and triggers the secretion of extracellular vesicles (EVs) containing cytotoxic oligomeric α-synuclein species. EVs released from HNE-treated neurons are internalized by healthy neurons which as a consequence degenerate. Levels of endogenously generated HNE are elevated in cultured cells overexpressing human α-synuclein, and EVs released from those cells are toxic to neurons. The EV-associated α-synuclein is located both inside the vesicles and on their surface, where it plays a role in EV internalization by neurons. On internalization, EVs harboring pathogenic α-synuclein are transported both anterogradely and retrogradely within axons. Focal injection of EVs containing α-synuclein into the striatum of wild-type mice results in spread of synuclein pathology to anatomically connected brain regions. Our findings suggest a scenario for late-onset PD in which lipid peroxidation promotes intracellular accumulation and then extrusion of EVs containing toxic α-synuclein species; the EVs are then internalized by adjacent neurons, so propagating the neurodegenerative process.
帕金森病(PD)的特征是在脑干、中脑和大脑皮层的易受影响的神经元群体中积累有毒的α-突触核蛋白聚集体。最近的研究结果表明,α-突触核蛋白病理学可以通过跨神经元传播,但潜在的分子机制尚不清楚。罕见的早发性家族性 PD 遗传学的进展表明,α-突触核蛋白的产量增加和/或自噬清除减少可能导致 PD。最常见的晚发性 PD 的原因尚不清楚,但可能涉及到α-突触核蛋白积累之前的代谢受损和氧化应激。有证据表明,在正常衰老过程中,大脑中的脂质过氧化产物 4-羟基壬烯醛(HNE)水平升高,在受α-突触核蛋白病理影响的大脑区域升高更为明显。在这里,我们报告 HNE 增加了内源性α-突触核蛋白在原代神经元中的聚集,并引发含有细胞毒性寡聚α-突触核蛋白的细胞外囊泡(EV)的分泌。从 HNE 处理的神经元释放的 EV 被健康神经元内化,从而导致神经元退化。在过度表达人α-突触核蛋白的培养细胞中,内源性产生的 HNE 水平升高,并且来自这些细胞的 EV 对神经元有毒。从这些细胞释放的 EV 相关的α-突触核蛋白位于囊泡内部和表面,在那里它在神经元内化 EV 中起作用。内化后,携带致病性α-突触核蛋白的 EV 在轴突中既可以向前也可以向后运输。将含有α-突触核蛋白的 EV 聚焦注射到野生型小鼠的纹状体中,导致突触核蛋白病理向解剖连接的脑区扩散。我们的研究结果表明了一种迟发性 PD 的情景,其中脂质过氧化促进细胞内积累,然后将含有毒性α-突触核蛋白的 EV 挤出;然后,相邻神经元内化 EV,从而传播神经退行性过程。